Highlights Sandoz Group AG

Stocks

SDZ

CH1243598427

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 09:01:26 10/06/2026 pm IST			5-day change	1st Jan Change
66.02 ^CHF	+2.20%		+4.96%	+14.14%

02/06	Moody's Changes Sandoz Group's Outlook on Sales Growth Expectations; Ratings Affirmed	MT
02/06	AlphaValue/Baader Europe Upgrades Sandoz Group to Add, Trims PT	MT

Highlights

01/06	Sandoz slips, despite bullish comments from AlphaValue
01/06	AlphaValue/Baader Europe Upgrades Sandoz Rating, Price Target on 'Strong' Biosimilar Moat	MT
28/05	Generic drugmaker Sandoz files anti-dumping complaint about Chinese antibiotics imports	RE
22/05	Sandoz Urges EU to Investigate Alleged Chinese Dumping of Antibiotic Ingredients	MT
22/05	Sandoz Urges EU to Investigate Alleged Chinese Dumping of Antibiotic Ingredients	MT
15/05	Sandoz Group AG Confirms European Commission Approval for Biosimilars Bysumlog® (Insulin Lispro) and Dazparda® (Insulin Aspart), Strengthening Position in Diabetes	CI
15/05	Sandoz Lands EU Nod for Insulin Biosimilars Bysumlog, Dazparda	MT
04/05	Berenberg Lifts Estimates for Sandoz Amid Potential for Diminishing Headwinds	MT
29/04	Sandoz: Remarkable biosimilar performance runs the show
29/04	Sandoz reports Q1 net sales of $2,756 mln	RE
29/04	Sandoz Books Higher Q1 Net Sales, Affirms FY26 Outlook	MT
15/04	Sandoz Partners With Rwanda for Direct Supply of Critical Medicines to Africa	MT
15/04	Sandoz Group AG Signs Agreement with Rwandan Government to Supply Critical Medicines	CI
02/04	Lotus Pharmaceutical Co., Ltd. entered into an agreement to acquire Philippines business from Sandoz Group AG.	CI
23/03	Sandoz Rating Downgraded as RBC Sees Fewer Near-term Biosimilar Opportunities; Price Target Up	MT
18/03	Samsung Bioepis and Sandoz Enter into Global License, Development and Commercialization Agreement for Up to Five Biosimilar Candidates	CI
18/03	Sandoz Group Partners With Samsung Bioepis for Biosimilar Drugs	MT
18/03	Sandoz announces partnership agreement with Samsung Bioepis	RE
10/03	Swiss Drugmaker Sandoz Group Launches Biosimilars Unit	MT
10/03	Sandoz Group AG Creates New Global Biosimilar Development, Manufacturing and Supply Unit	CI
04/03	Berenberg Says FY26 'Year for Delivery' for Sandoz; Price Target Up	MT
25/02	Swiss Market Index Retreats Amid Earnings Buzz; Sandoz, Leclanché in Green	MT
25/02	Switzerland's Sandoz Posts Improved FY25 Net Income, Sales	MT
25/02	Sandoz FY sales USD 11.1 bln vs IBES estimate USD 11.1 bln	RE
25/02	Sandoz Group Ag Provides Earnings Guidance for the Full Year 2026	CI